Results 21 to 30 of about 211 (106)

The cellular and molecular mechanisms providing therapeutic efficiency of gistokhrom

, 2017
The review presents the screening of the therapeutic effects of the Russia drug “Histochrome”, active substance of which is quinoid pigment marine - echinochrome A (2,3,5,6,8-pentahydroxy-7-ethyl-1,4-naphthoquinone). Assessing the pharmacological aspects
Yakov F Zverev, Olga S Talalaeva, Valeriy M Bryukhanov   +2 more
core   +1 more source

The use of histochrome in the complex treatment of the patients with acute coronary syndrome with ST segment depression diagnosed on ECG [PDF]

, 2015
© 2014 the author(s). The article presents high clinical efficiency and the absence of side effects of the use of histochrome in the complex treatment of the patients with acute coronary syndrome with ST segment depression diagnosed on ...
Kim Z., Khusnullina E., Ishkineev F., Gaifullina R.   +3 more
core  

Echinochrome A inhibits epithelial–mesenchymal transition and induces cell death mediated by DNA damage in human triple-negative breast cancer cells

Journal of Functional Foods
Echinochrome A (Ech A), a marine-derived compound from Scaphechinus mirabilis, is known for its potent antioxidant activity. Its pharmacological derivative, Histochrome, is used to treat ischemia and cardiovascular disorders.
Soon Yong Park, Mi-So Jeong, Cong So Tran, Jinyoung Lee, Da-Young Eum, Seyeon Jung, Elena A. Vasileva, Seoung Rak Lee, Hyoung Kyu Kim, Natalia P. Mishchenko, Jin Han, Yoo Jin Choi, Si Ho Choi, Hwayoung Yun, Kyu Heo   +14 more
doaj   +1 more source

Влияние биологически активных веществ из морских организмов на формирование биопленки Yersinia Pseudotuberculosis на биотической поверхности

, 2017
В сообщении представлены результаты изучения влияния пентакана и гистохрома - БАВ из морских гидробионтов, на формирование биопленки Y. pseudotuberculosis на биотической поверхности. Установлено, что Y.
Долматова Л.С., Елисейкина М.Г., Масюк А.Г., Тимченко Н.Ф., Терентьева Н.А.   +4 more
core   +1 more source

The use of histochrome in the complex treatment of the patients with acute coronary syndrome with ST segment depression diagnosed on ECG

, 2020
© 2014 the author(s). The article presents high clinical efficiency and the absence of side effects of the use of histochrome in the complex treatment of the patients with acute coronary syndrome with ST segment depression diagnosed on ...
Kim Z., Khusnullina E., Ishkineev F., Gaifullina R.   +3 more
core  

Применение гистохрома в лечении больных первичной открытоугольной глаукомой [PDF]

, 2017
PURPOSE: To study the efficiency of complex treatment of primary open-angle glaucoma (POAG), that includes histochrome application both intraoperatively in the course of trabeculectomy (STE) and combined with magnetic therapy in the early postoperative ...
В. Я. Мельников, D. V. Grigoriev, V. Y. Melnikov, N. V. Philina, Д. В. Григорьев, А. М. Вершинин, Н. В. Филина, N. S. Tedeeva, A. M. Vershinin, Наталья Сергеевна Тедеева   +9 more
core  

The Use of Histochrome in the Complex Treatment of the Patients with Acute Coronary Syndrome with ST Segment Depression Diagnosed on ECG

Modern Applied Science, 2014
© 2014 the author(s). The article presents high clinical efficiency and the absence of side effects of the use of histochrome in the complex treatment of the patients with acute coronary syndrome with ST segment depression diagnosed on ECG.
Kim Z., Ishkineev F., Khusnullina E., Gaifullina R.   +3 more
openaire   +4 more sources

Quinoid Pigments of Sea Urchins Scaphechinus mirabilis and Strongylocentrotus intermedius: Biological Activity and Potential Applications. [PDF]

Mar Drugs, 2022
Ageenko NV, Kiselev KV, Odintsova NA.
europepmc   +1 more source

Multiple Effects of Echinochrome A on Selected Ion Channels Implicated in Skin Physiology. [PDF]

Mar Drugs, 2023
Kim SE, Chung EDS, Vasileva EA, Mishchenko NP, Fedoreyev SA, Stonik VA, Kim HK, Nam JH, Kim SJ.   +8 more
europepmc   +1 more source

Cardiomyocyte Damage: Ferroptosis Relation to Ischemia-Reperfusion Injury and Future Treatment Options. [PDF]

Int J Mol Sci, 2023
Laukaitiene J, Gujyte G, Kadusevicius E.
europepmc   +1 more source